ATN 061: PRESERVATION AND EXPANSION OF T-CELL SUBSETS FOLLOWING HAART DE-INTE

ATN 061：HAART DE-INTE 后 T 细胞亚群的保存和扩增

• 批准号: 7951106
• 负责人: LAWRENCE James D'ANGELO
• 金额: $ 0.28万
• 依托单位: CHILDREN'S RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-12-01 至 2010-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7951106
• 关键词: AIDS/HIV problem; Acquired Immunodeficiency Syndrome; Adolescent; Adolescent Medicine Trials Network; Atazanavir; Biological Preservation; CD4 Positive T Lymphocytes; Clinical Research; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; HIV; Highly Active Antiretroviral Therapy; Institution; Intervention; RNA; Research; Research Personnel; Resources; Ritonavir; Source; T-Lymphocyte Subsets; United States National Institutes of Health; young adult

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Following Haart De-Intensification to Atazanavir/Ritonavir (Atv/R) in Adolescents and Young Adults with CD4 + T Cells 350 and HIV RNA 100,000 Initiating Haart, Version 1.0 Dated June 25, 2007. A Multi-Center Study of the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)

这个子项目是许多利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 CD 4 + T细胞350和HIV RNA 100，000的青少年和年轻人接受Atazanavir/Ritonavir（Atv/R）Haart减敏后，启动Haart，版本1.0，日期：2007年6月25日。艾滋病毒/艾滋病干预青少年医学试验网络（ATN）的多中心研究